Pioneering a new modality of microbial cell therapy
About Federation Bio
Federation Bio is a clinical stage company developing high diversity microbial consortia that are therapeutically optimized for efficacy and safety and are manufactured from purified cell lines. Our first-in-class consortia platform is designed to enable our therapeutics to target multiple mechanisms of action and stably engraft in patients for durable benefit. FB-001, our lead program, is the largest and most complete live biotherapeutic product ever tested in humans, containing 148 distinct strains of bacteria delivered via oral capsule.
At Federation Bio, we use bioinformatics to design fit-for-purpose consortia. Our therapeutics can hit multiple MOAs and offer the potential for curative treatments in many different indications.
Who We Are
We are a diverse group of scientists from a range of disciplines – genetics, microbiology, bioinformatics, and immunology – driven by a shared passion for creating medicines that make a difference.
Join Our Team
Our employees are the key to our cutting-edge, collaborative, and creative science. We are committed to recruiting and investing in exceptional people.